ÂÜÀòÂÒÂ×

Rupsa Basu holds an M.Sc and Ph.D. Rupsa has a diverse range of work experience in the field of science and research.

Beginning in 2011, they worked as a Summer Trainee at the Indian Institute of Chemical Biology, where they investigated the association of NQO1 C609T polymorphism among tobacco chewers and studied the effects of tobacco chewing on oral submucous fibrosis population.

Rupsa continued their research work at the same institute in 2012 as a Project Trainee, conducting genotyping and subtyping of Helicobacter pylori strains and exploring signal transduction pathways in cancer cells.

In 2013, they worked as a Research Fellow at the Indian Institute of Chemical Biology, where they generated a graphene nanoparticle-based drug delivery system for the treatment of Chronic Myeloid Leukemia (CML) and designed new molecules to increase drug efficacy in cancer.

From 2014 to 2019, Rupsa worked at Michigan Technological University as a Doctoral Researcher, investigating the development of preventive candidate vaccines against Zika and Chikungunya viruses and studying the role of brain (pro)renin in salt-sensitive hypertension.

In 2016, they briefly served as an Instructor of Summer Youth Programs at Michigan Technological University, teaching microbiology and medical physiology courses.

In 2018, Rupsa became an Executive Board Member and Program Chair at Cheeky Scientist, contributing to the organization's initiatives.

In 2019, they joined TechnoVax, Inc. as a Research and Development Lead Scientist, leading and executing vaccine development projects for SARS-CoV-2 (COVID-19) and Influenza.

In 2021, they worked as a Scientist and Clinical Immunologist at Helaina, where they generated strategies for product development and executed preclinical studies for infant nutrition ingredients. Rupsa also contributed to the company's mission of revolutionizing the infant nutrition space.

In the same year, they joined Humane Genomics as a Lead Scientist, focusing on precision oncolytic virotherapy.

Most recently, in 2022, they have taken on the role of Director At Large at the Healthcare Businesswomen's Association, where they represent the marketing and communications function on the chapter board and oversees various responsibilities to support the chapter's goals and objectives.

Overall, Rupsa Basu's work experience showcases their expertise and contributions in the areas of molecular biology, vaccine development, medical research, and leadership roles within the scientific community.

Rupsa Basu earned their Bachelor of Science (B.Sc.) degree in Zoology/Animal Biology from University of Calcutta- Bethune College from 2007 to 2010. Rupsa then pursued a Master of Science (M.Sc.) degree in Molecular Biology and Genetics at Presidency University from 2010 to 2012. Rupsa Basu furthered their education at Michigan Technological University, where they obtained a Doctor of Philosophy (Ph.D.) degree in Biochemistry and Molecular Biology from 2014 to 2019, achieving a GPA of 4.0.

In addition to their formal education, Rupsa Basu has gained multiple certifications. These include the HBA Spark Award Winner from the Healthcare Businesswomen's Association in January 2023. Rupsa also completed the Ethical and Regulatory Aspects of Clinical Research certification from The National Institutes of Health in November 2021. Furthermore, Rupsa Basu obtained certifications such as ORAQ Regulatory Affairs from Duke University School of Medicine, Fundamentals of Clinical & Translational Science from Mayo Clinic, and Introduction to the Principles and Practice of Clinical Research from The National Institutes of Health. Rupsa also completed certifications in various scientific topics, including cancer immunotherapy, CRISPR-Cas9 genome engineering, and animal care and use.

Additionally, Rupsa Basu possesses industry-related certifications and training, including learning Salesforce and working as an R&D Scientist. Rupsa has received certifications related to animal care and research protocols from the Collaborative Institutional Training Initiative at the University of Miami.

Based on the provided information, it is evident that Rupsa Basu has a strong academic background in biochemistry, molecular biology, genetics, and animal biology. Rupsa has also obtained various certifications that showcase their expertise in clinical research and industry-related skills.